Application 204038
- Type
- ANDA
- Sponsor
- SCIEGEN PHARMS INC
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | VALSARTAN | VALSARTAN | TABLET;ORAL | 40MG | No | No |
| 002 | VALSARTAN | VALSARTAN | TABLET;ORAL | 80MG | No | No |
| 003 | VALSARTAN | VALSARTAN | TABLET;ORAL | 160MG | No | No |
| 004 | VALSARTAN | VALSARTAN | TABLET;ORAL | 320MG | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 50228-132 | Valsartan | Valsartan | ScieGen Pharmaceuticals, INC. | ANDA | Current |
| 50228-132 | Valsartan | Valsartan | ScieGen Pharmaceuticals, INC. | ANDA | Current |
| 50228-133 | Valsartan | Valsartan | ScieGen Pharmaceuticals, INC. | ANDA | Current |
| 50228-133 | Valsartan | Valsartan | ScieGen Pharmaceuticals, INC. | ANDA | Current |
| 50228-134 | Valsartan | Valsartan | ScieGen Pharmaceuticals, INC. | ANDA | Current |
| 50228-134 | Valsartan | Valsartan | ScieGen Pharmaceuticals, INC. | ANDA | Current |
| 50228-135 | Valsartan | Valsartan | ScieGen Pharmaceuticals, INC. | ANDA | Current |
| 50228-135 | Valsartan | Valsartan | ScieGen Pharmaceuticals, INC. | ANDA | Current |